Skip to main content
If you continue browsing this website, you agree to our policies:
Cookie Statement
Privacy Policy
Personal Data Protection Policy
Continue
x
Welcome to the Wits RHI eLearning Portal.
Font size:
A
A
A
×
Forgot your username or password?
Search
Close
Log in
Close
Home
Courses
Shandukani Research Centre
Protocols and MOPs
Course categories
Gophelega Project
Gophelega Project / Technical
Gophelega Project / Behavioural Skills
Gophelega Project / Legislative
Gophelega Project / System Skills
Implementation Science
Shandukani Research Centre
Shandukani Research Centre / SUSARS
Shandukani Research Centre / SUSARS / Study: GSUS-412-5624
Shandukani Research Centre / SUSARS / Study: GSUS-621-6289 | GS-US-200-6712 | GS-US-621-6463.
Shandukani Research Centre / SUSARS / Study: M72 CommuniTB (TBV02-301)
Shandukani Research Centre / SUSARS / Study: CARLA
Shandukani Research Centre / SUSARS / Study: C3671032
Shandukani Research Centre / SUSARS / Study: C4591048
Shandukani Research Centre / SUSARS / Study: A5359, IMPAACT 2017 and IMPAACT 2036
Shandukani Research Centre / SUSARS / Study: GS-US-200-6712 | GS-US-380-6463
Shandukani Research Centre / SUSARS / Study: MK-1439-1439A-066
Shandukani Research Centre / SOPs
Shandukani Research Centre / SOPs / General
Shandukani Research Centre / SOPs / RSV_IMPACT
Shandukani Research Centre / Protocols and MOPs
Wits RHI Research Team
Wits RHI Research Team / Orientation
Wits RHI Research Team / Standard Operating Procedures (SOPs)
Wits RHI Research Team / Standard Operating Procedures (SOPs) / Pharmacy
Wits RHI Research Team / Standard Operating Procedures (SOPs) / Laboratory
Project PrEP
Project PrEP / SOPs
Project PrEP / SOPs / Research SOPs
Project PrEP / SOPs / Data Management SOPs
Project PrEP / SOPs / Decentralisation
Project PrEP / SOPs / Community Engagement
General
Search courses
Search courses
IMPAACT 2036 eCRF Completion Guide Version 2.0.0.2_Revised 23 July 2025
Enter this course
IMPAACT 2036 Lab Processing Chart Version 2.0_Revised 27 May 2025
Enter this course
IMPAACT 2036 Protocol Version 2.0 and MOP Version 3.0
Enter this course
IMPAACT 2036 MOP: Phase I/II Study of the Safety, Tolerability, Acceptability & Pharmacokinetics of Oral & Long-Acting Injectable Cabotegravir & Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to
Enter this course
Should you have any navigation queries, please email wrhitraining@academicadvance.co.za.
Hide sidebars
